Have £2k to invest? Why I think this FTSE 100 dividend stock could pay you for 50 years
One of my main investing goals is to build a portfolio of stocks that will provide a reliable income for many years. In this article I’m going to look at a …
One of my main investing goals is to build a portfolio of stocks that will provide a reliable income for many years. In this article I’m going to look at a …
Software firm Micro Focus (MCRO) and pharmaceutical giant AstraZeneca (AZN) have buoyed the FTSE 100, driving the index to fresh four-month …
It also puts Micro Focus firmly at the top of the list of FTSE 100 risers, by far – drugs developer AstraZeneca (AZN) is the next biggest riser, up barely …
The FTSE 100 was up 21 points (0.3%) at 7,223. If the Footsie’s advance appears to be running out of steam the same could be said of Wall Street.
Low mortgage rates and a less aggressive attitude from lenders means fewer are having their homes seized.
If you want to build a portfolio of blue-chip income stocks at the click of a button, you can’t go wrong with the FTSE 100, in my opinion. However, the …
FTSE 100 up 0.4 pct. * FTSE 250 up 0.1 pct. * Micro Focus top blue-chip gainer after results. * AstraZeneca rises on Q4 sales beat, strong forecast.
The cake chain and sister brand Philpotts have been bought out of administration, saving 117 shops.
The Dutch government tweets out a furry creature warning to firms about the impact of Brexit.
The FTSE 100 rose 0.3 percent by 0959 GMT and the FTSE 250 was up 0.1 percent. The midcap gains were limited by a plunge in medical-device …
It’s not always easy to tell the difference between bargain buys and shares that deserve to be cheap. The two stocks I’m going to look at today provide …
It’s not always easy to tell the difference between bargain buys and shares that deserve to be cheap. The two stocks I’m going to look at today provide …
Morgan Stanley expects stock returns to be driven primarily by company-specific factors in the near-term.
“The pharmaceutical sector was the principal driver of the FTSE 100 on Thursday with the blue-chip index rising 0.2% to 7,206. AstraZeneca was the …
FTSE100 `continues to trade higher for 5th consecutive day following more than 50 points jump yesterday. The index is trading higher following …
The FTSE 100 has managed to break through the 7196 level this week, negating the downtrend that has been in play since the peak of May 2018.
Good morning!
I’m not going to waste my time responding to the tripe in yesterday’s comments section. Incidentally, I suggested to the boss that Stockopedia restricts the thumbs down facility to paying subscribers only. He agreed, and that’s been imple…
Good morning!
I’m not going to waste my time responding to the tripe in yesterday’s comments section (I can’t anyway, as Ed has closed the thread). Incidentally, I suggested to the boss that Stockopedia restricts the thumbs down facility to paying subs…
The FTSE 100 is seen slightly higher ahead of Thursday’s open following both Wall Street and Asian stock benchmarks which showed cautious …
(For a live blog on European stocks, type LIVE/ in an Eikon news window). * FTSE 100 up 0.4 pct. * FTSE 250 down 0.1 pct. * Micro Focus top …
The economy has been hit by a slowdown in the global economy and problems in the car sector.
Feb 14 (Reuters) – Britain’s FTSE 100 index is seen opening 13 points lower at 7,178 on Thursday, according to financial bookmakers, while FTSE 100 …
(Adds company news items and futures). Feb 14 (Reuters) – Britain’s FTSE 100 index is seen opening 13 points lower at 7,178 on Thursday, according …
The FTSE 100 fell by 12% from 7,648 to 6,734, which left the large-cap index at levels first reached almost 20 years ago in 1999. More importantly …
The FTSE 100 looks set to open higher this morning, finding support in the latest data out of China. AstraZeneca’s (LON:AZN) results will be in focus …
The aircraft manufacturer ends production of the superjumbo after key buyer Emirates cuts order.
It was billed as the future of air travel, but airlines increasingly saw the jet as too big and inefficient.
Morgan Stanley sees declining corporate earnings in 2019, and does not believe that the Fed’s new dovish stance can stop the slide.
Gene Levoff is accused of engaging in insider trading on several occasions between 2011 and 2016.
Securing a UK-EU trade deal will be top a priority over the months ahead.